TITLE

Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial)

AUTHOR(S)
Reiko Aoyagi; Hiromichi Hamada; Yasunori Sato; Hiroyuki Suzuki; Yoshihiro Onouchi; Ryota Ebata; Kengo Nagashima; Moe Terauchi; Masaru Terai; Hideki Hanaoka; Akira Hata
PUB. DATE
December 2015
SOURCE
BMJ Open;2015, Vol. 5 Issue 12, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
111412282

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics